共 50 条
- [31] The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo Molecular Medicine, 2005, 11 : 1 - 15
- [38] A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma Annals of Hematology, 2010, 89 : 185 - 190